DK1100922T3 - Anvendelser af én eller flere borreliacide epitoper på ydermembranprotein C fra Borrelia burgdorferi (OspC) som vaccine - Google Patents
Anvendelser af én eller flere borreliacide epitoper på ydermembranprotein C fra Borrelia burgdorferi (OspC) som vaccineInfo
- Publication number
- DK1100922T3 DK1100922T3 DK99938897T DK99938897T DK1100922T3 DK 1100922 T3 DK1100922 T3 DK 1100922T3 DK 99938897 T DK99938897 T DK 99938897T DK 99938897 T DK99938897 T DK 99938897T DK 1100922 T3 DK1100922 T3 DK 1100922T3
- Authority
- DK
- Denmark
- Prior art keywords
- ospc
- borrelia burgdorferi
- borreliacid
- epitopes
- vaccine
- Prior art date
Links
- 108700023315 OspC Proteins 0.000 title abstract 3
- 241000589969 Borreliella burgdorferi Species 0.000 title abstract 2
- 101710203379 Outer membrane porin C Proteins 0.000 title 1
- 101710160101 Outer membrane protein C Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 239000012634 fragment Substances 0.000 abstract 3
- 208000016604 Lyme disease Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000001449 borreliacidal effect Effects 0.000 abstract 1
- 238000013399 early diagnosis Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/828—Bacterial vaccine for canidae or mustelidae, e.g. dogs, foxes, minks
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9495598P | 1998-07-31 | 1998-07-31 | |
| PCT/US1999/017270 WO2000006745A1 (en) | 1998-07-31 | 1999-07-30 | Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1100922T3 true DK1100922T3 (da) | 2008-06-16 |
Family
ID=22248146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99938897T DK1100922T3 (da) | 1998-07-31 | 1999-07-30 | Anvendelser af én eller flere borreliacide epitoper på ydermembranprotein C fra Borrelia burgdorferi (OspC) som vaccine |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US6210676B1 (da) |
| EP (1) | EP1100922B1 (da) |
| JP (1) | JP3631960B2 (da) |
| AT (1) | ATE386805T1 (da) |
| AU (1) | AU5328299A (da) |
| CA (1) | CA2332570C (da) |
| CY (1) | CY1107944T1 (da) |
| DE (1) | DE69938183T2 (da) |
| DK (1) | DK1100922T3 (da) |
| ES (1) | ES2302385T3 (da) |
| NO (1) | NO329227B1 (da) |
| PT (1) | PT1100922E (da) |
| WO (1) | WO2000006745A1 (da) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7008625B2 (en) | 1993-11-01 | 2006-03-07 | Research Foundation Of The State University Of New York | Recombinant constructs of Borrelia burgdorferi |
| AU5751000A (en) | 1999-06-18 | 2001-01-09 | Brook Biotechnologies, Inc. | Groups of borrelia burgdorferi and borrelia afzelii that cause lyme disease in humans |
| EP1939294A1 (en) * | 2000-08-18 | 2008-07-02 | Research Foundation Of State University Of New York | Recombinant constructs of borrelia burgdorferi |
| PT1311682E (pt) * | 2000-08-18 | 2008-03-11 | Brookhaven Sciences Ass Llc | Construcões recombinantes de borrelia burgdorferi |
| DK1311540T3 (da) | 2000-08-18 | 2008-04-28 | Brookhaven Sciences Ass Llc | Ændret OspA af Borrelia Burgdorferi |
| EP1865062A3 (en) * | 2000-08-18 | 2008-01-09 | Research Foundation Of State University Of New York | Altered OspA of Borrelia burgdorferi |
| US20020142355A1 (en) * | 2000-11-14 | 2002-10-03 | Baylor College Of Medicine | Methods for the in vivo biotin labeling of polypeptides |
| KR101192127B1 (ko) | 2006-11-03 | 2012-10-17 | 쉐링-프라우 리미티드 | 개 라임병 백신 |
| EP2361930A3 (en) | 2007-03-26 | 2011-10-26 | Dako Denmark A/S | Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases |
| EP2167536A1 (en) | 2007-07-03 | 2010-03-31 | Dako Denmark A/S | Mhc multimers, methods for their generation, labeling and use |
| US10611818B2 (en) | 2007-09-27 | 2020-04-07 | Agilent Technologies, Inc. | MHC multimers in tuberculosis diagnostics, vaccine and therapeutics |
| US10968269B1 (en) | 2008-02-28 | 2021-04-06 | Agilent Technologies, Inc. | MHC multimers in borrelia diagnostics and disease |
| EP2283031B1 (en) * | 2008-05-02 | 2017-04-12 | Virginia Commonwealth University | Lyme disease vaccine |
| WO2010009735A2 (en) | 2008-07-23 | 2010-01-28 | Dako Denmark A/S | Combinatorial analysis and repair |
| GB0817244D0 (en) | 2008-09-20 | 2008-10-29 | Univ Cardiff | Use of a protein kinase inhibitor to detect immune cells, such as T cells |
| WO2010037402A1 (en) | 2008-10-02 | 2010-04-08 | Dako Denmark A/S | Molecular vaccines for infectious disease |
| CA2812759A1 (en) | 2010-09-27 | 2012-04-12 | Cornell University | Methods for diagnosing lyme disease |
| JP2013542942A (ja) * | 2010-10-20 | 2013-11-28 | ヴァージニア コモンウェルス ユニバーシティ | 多価キメラｏｓｐｃワクシノーゲンおよび診断用抗原 |
| US9562079B2 (en) | 2012-04-18 | 2017-02-07 | Zoetis Services Llc | Vaccines and methods to treat lyme disease in dogs |
| UY34745A (es) | 2012-04-18 | 2013-11-29 | Zoetis Llc | Vacunas y procedimientos para tratar la enfermedad de lyme en perros |
| WO2016049148A1 (en) | 2014-09-24 | 2016-03-31 | Wellstat Diagnostics, Llc | Compositions and methods for te diagnosis of lyme disease |
| US11883476B2 (en) | 2017-12-04 | 2024-01-30 | Intervet Inc. | Canine lyme disease vaccine |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5777095A (en) | 1988-10-24 | 1998-07-07 | Symbicom Aktiebolag | Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90 |
| US5385826A (en) | 1989-04-21 | 1995-01-31 | Gundersen Medical Foundation, Ltd. | Diagnostic assay for lyme disease |
| DE4015911A1 (de) | 1989-09-19 | 1991-03-28 | Max Planck Gesellschaft | Impfstoff gegen die lyme-krankheit |
| EP0519016A1 (en) | 1990-03-07 | 1992-12-23 | F.Hoffmann-La Roche & Co. Aktiengesellschaft | Method for diagnosis of lyme disease |
| JPH06501382A (ja) | 1990-06-15 | 1994-02-17 | エール ユニバーシティ | ライム病の予防および診断に用いる組成物および方法 |
| ATE162550T1 (de) | 1993-04-29 | 1998-02-15 | Immuno Ag | Ospc-antigen-impfstoffe immunogene zusammensetzung zur vorbeugung und behandlung von lyme-krankheit und rekombinante verfahren zur herstellung von derartige antigene |
| US5656451A (en) | 1993-07-30 | 1997-08-12 | Yale University | OspE, OspF, and S1 polypeptides in borrelia burgdorferi |
| CA2175579A1 (en) * | 1993-10-26 | 1995-05-04 | Chang Yi Wang | Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics |
| US5558993A (en) | 1994-06-17 | 1996-09-24 | The Regents Of The University Of California | Cloned Borrelia burgdorferi virulence protein |
| US5853987A (en) | 1995-04-24 | 1998-12-29 | The Texas A & M University System | Decorin binding protein compositions and methods of use |
| ATE284974T1 (de) | 1996-03-26 | 2005-01-15 | Cylex Inc | Verfahren zur messung der lymphozytenfunktion |
| CA2253374C (en) * | 1996-05-02 | 2004-07-20 | Marianne Jartved Mathiesen | Novel osp-c derived peptide fragments |
| US5846946A (en) | 1996-06-14 | 1998-12-08 | Pasteur Merieux Serums Et Vaccins | Compositions and methods for administering Borrelia DNA |
-
1999
- 1999-07-30 DK DK99938897T patent/DK1100922T3/da active
- 1999-07-30 PT PT99938897T patent/PT1100922E/pt unknown
- 1999-07-30 JP JP2000562527A patent/JP3631960B2/ja not_active Expired - Fee Related
- 1999-07-30 US US09/364,083 patent/US6210676B1/en not_active Expired - Lifetime
- 1999-07-30 DE DE69938183T patent/DE69938183T2/de not_active Expired - Lifetime
- 1999-07-30 EP EP99938897A patent/EP1100922B1/en not_active Expired - Lifetime
- 1999-07-30 WO PCT/US1999/017270 patent/WO2000006745A1/en active IP Right Grant
- 1999-07-30 AT AT99938897T patent/ATE386805T1/de active
- 1999-07-30 CA CA002332570A patent/CA2332570C/en not_active Expired - Lifetime
- 1999-07-30 ES ES99938897T patent/ES2302385T3/es not_active Expired - Lifetime
- 1999-07-30 AU AU53282/99A patent/AU5328299A/en not_active Abandoned
-
2000
- 2000-08-30 US US09/651,419 patent/US6464985B1/en not_active Expired - Lifetime
-
2001
- 2001-01-24 NO NO20010412A patent/NO329227B1/no not_active IP Right Cessation
-
2008
- 2008-05-13 CY CY20081100502T patent/CY1107944T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1107944T1 (el) | 2013-09-04 |
| JP2002523019A (ja) | 2002-07-30 |
| EP1100922B1 (en) | 2008-02-20 |
| PT1100922E (pt) | 2008-05-30 |
| ES2302385T3 (es) | 2008-07-01 |
| NO329227B1 (no) | 2010-09-20 |
| AU5328299A (en) | 2000-02-21 |
| US6464985B1 (en) | 2002-10-15 |
| WO2000006745A1 (en) | 2000-02-10 |
| DE69938183T2 (de) | 2009-02-19 |
| ATE386805T1 (de) | 2008-03-15 |
| NO20010412L (no) | 2001-03-29 |
| EP1100922A1 (en) | 2001-05-23 |
| NO20010412D0 (no) | 2001-01-24 |
| CA2332570C (en) | 2009-12-08 |
| JP3631960B2 (ja) | 2005-03-23 |
| CA2332570A1 (en) | 2000-02-10 |
| DE69938183D1 (de) | 2008-04-03 |
| US6210676B1 (en) | 2001-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1100922T3 (da) | Anvendelser af én eller flere borreliacide epitoper på ydermembranprotein C fra Borrelia burgdorferi (OspC) som vaccine | |
| CY1118443T1 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
| WO2003078600A3 (en) | Human monoclonal antibodies to influenza m2 protein and methods of making and using same | |
| NO995458L (no) | Humane 12-lignende reseptorproteiner, beslektede reagenser og metoder | |
| HUP0202532A2 (hu) | Ko-stimulátor szignál-transzdukciós molekula (AILIM) elleni humán monoklonális antitest és gyógyászati alkalmazása | |
| CY1109725T1 (el) | Ειδικες δεσμευομενες πρωτεϊνες και χρησεις αυτων | |
| NO2010021I1 (no) | Denosumab | |
| DK2316852T3 (da) | Stabiliserede enkeltdomæne-antistoffer | |
| CY1108545T1 (el) | Πρωτεϊνες υπομοναδας υποδοχεα κυτοκινης θηλαστικου, σχετικα αντιδραστηρια και μεθοδοι | |
| ATE194291T1 (de) | Neutralisierende monoklonale antikörper gegen respiratorischen synzytialvirus | |
| ATE283289T1 (de) | Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten | |
| BRPI0513135A (pt) | bibliotecas de polinucleotìdeos, método de produção das mesmas, método de identificação de um polinucleotìdeo, região de ligação, meio adequado para uso em um, dispositivo eletrÈnico e dispositivo | |
| WO2007133623A3 (en) | Peptide diagnostic agent for lyme disease | |
| FR2794865B1 (fr) | Methode de detection precoce des flavivirus et ses applications | |
| EP2186884A2 (en) | HCV-anti-core monoclonal antibody | |
| DK0528932T3 (da) | Protein associeret med akut pancreatitis og midler til diagnose af akut pancreatitis | |
| WO2005016132A3 (en) | Diagnostics for sars virus | |
| DE60120621D1 (de) | Lawsonia intracellularis Impfstoff | |
| ATE188746T1 (de) | Adeno-assozierter virus - dessen diagnostischen anwendung für frühe abtreibung | |
| DE69737323D1 (de) | Adhesin aus heliobacter pylori, welches an blutgruppenantigene bindet | |
| WO2003026700A3 (fr) | Compositions pour la vectorisation d'anticorps a travers la barriere hematoencephalique et leur utilisation pour le diagnostic ou le traitement des maladies du systeme nerveux central | |
| WO2004020609A3 (en) | Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection | |
| Sun et al. | Immunodiagnosis of human dirofilariasis by enzyme-linked immunosorbent assay using recombinant DNA-derived fusion protein | |
| DK1417222T3 (da) | Isolerede polypeptider baseret på den neutraliserende epitop af p17-proteinet fra HIV egnet til vacciner samt neutraliserende anti-p17-antistoffer, der specifikt genkender nævnte neutraliserende epitop | |
| King | Monoclonal antibody studies on rabies-related viruses |